CS Paper Radar

ReproBAIT: Can coding agents build their own biological AI tools?

Shiv Muthupandiyan, Tolga H. Dur, Mac Walker, Timo Flesch, Mahmoud Ghanem, Steph Suddell, Giles Harper-Donnelly, Sophie Rose, Jasper Götting, Coleman Breen, Jake Pencharz

cs.AI cs.CYcs.LG ·submitted 2026-10-14 08:50 UTC · v1
code/data

Abstract

Large language models are increasingly competent at leveraging scientific knowledge and existing computational tools to execute complex workflows. At present, little information exists on their ability to reconstruct tools when given limited descriptions of such tools. We introduce an evaluation titled ReproBAIT (Reproducing Biological AI Tools), which measures the ability of coding agents to design, implement, and train biological AI tools taken from published research across a range of information access conditions. The coding agent is securely sandboxed without internet access and receives training data, a fixed time and compute budget, and limited information about the tool to replicate. We then score the reproduced biological AI tool based on its performance (tool-specific metrics) on held-out data. We evaluated a set of biological AI tools of varying complexities: ProteinMPNN, an inverse protein folding tool, RFdiffusion3, an all-atom generative diffusion tool, and a closed-source molecular design tool. We institute a methodology to check for memorisation, as the open source tools are likely to be included in models' pretraining corpus. Across a range of leading closed- and open-source coding agents, we find substantial reproduction capability for some selected tools, though limited capability for a highly complex tool. We find moderate evidence consistent with memorisation, varying across coding agents. These results suggest that tool developers need to be increasingly cautious when releasing information about the tools publicly; re-creation of the tool based on such information could undermine a tool's commercial value or invalidate dual-use managed access strategies.

Closest papers

Nearest neighbours by meaning across the whole index.

AgentFold: Closed-Loop Agentic Search for Protein Folding Model Design

cs.AI ·2026-08-27 ·Mingquan Liu, Jiangyu Chen, Hanqun Cao, Xujun Zhang, Pengsen Ma +7 more
top venuecode/data similarity 0.78
Abstract

Scientific LLM agents have shown promise in literature reasoning, tool use, and experiment planning, but it remains unclear whether they can autonomously improve large, tightly coupled scientific machine-learning systems through executable code changes and computationally expensive validation. We study this question in protein folding, where progress requires coordinated architectural modifications, multi-objective evaluation, and domain-aware interpretation. We present AgentFold, a multi-agent framework that formulates folding-model development as a closed-loop search over executable code variants. Starting from ESMFold, AgentFold proposes hypotheses, implements and debugs code-level modifications, evaluates model variants, analyzes experimental outcomes, and stores both successful and failed interventions in structured memory. An MCTS-style policy allocates computational resources across high-scoring search branches. On an engineering-scale protein-folding codebase comprising more than 2,000 lines of code, AgentFold explores approximately 80 model variants using approximately 5,000 GPU-hours and 170 million LLM tokens. Under a matched computational budget, AgentFold improves the best lDDT by 7.5% over independent Codex proposals and outperforms a random-search control. Beyond model improvement, the resulting intervention traces reveal recurring empirical design patterns: stable gains tend to arise from early, soft, learnable priors and gated refinement, whereas direct geometric perturbations and geometry-conditioned feedback often destabilize training. The code and experimental resources are publicly available at https://github.com/lmqfly/AgentFold.

0.51

El Agente Fármaco: A Scalable AI Scientist for Drug Discovery

cs.AI cs.MAq-bio.BM ·2026-11-02 ·Marcel Müller, Mohammad Ghazi Vakili, Yoshihiro Ogura, Ella Ashoori, Shimeng Wang +11 more
benchmark similarity 0.73
Abstract · 63 pages, 13 figures, including Supporting Information

Computational drug discovery offers a growing range of tools for proposing and evaluating molecules, but combining them and deciding what to do next still requires substantial expert effort. Here, we introduce El Agente Fármaco, an AI scientist that uses modern large language model (LLM) technology to turn discovery goals expressed in everyday language into complex, scalable computational screening workflows. The agentic harness selects scientific tools, reviews their results, and adjusts subsequent steps to the target and the user's objectives. Our approach centers on a shared scientific memory: Fármaco Atlas, which stores molecules, structures, and results together with their provenance -- a record of how they were obtained. The agent uses targeted database queries to retrieve the evidence needed for each decision. A single request can launch calculations for an entire collection of molecules, without requiring a separate LLM decision for every compound. This design limits the information the model must process as screening collections grow, while keeping the underlying results available for inspection and further analysis. The integrated tools support molecule generation, prediction of binding and molecular properties, and searches for compounds available for purchase. In a retrospective comparison with an expert-led campaign, the agent proposed chemically distinct candidates with competitive docking scores and higher calculated drug-likeness under explicitly imposed selection criteria. In a 22-task benchmark against plain tool calls and Codex, the agent achieved the highest observed mean model-judged score, with lower median cumulative token use and peak context. Fármaco provides a foundation for flexible, scalable drug discovery workflows that connect scientific reasoning with an enduring, traceable record of computational work.

0.08

Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

cs.AI cs.CYq-bio.QM ·2026-09-05 ·Bryce Cai, Geetha Jeyapragasan, Samira Nedungadi, Jake Yukich, Seth Donoughe
publishedbenchmarkhighly cited similarity 0.72
Abstract · Last revised in February 2026; presented without further revision. An earlier revision at was presented at the NeurIPS 2025 Workshop on Bios…

We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows. ABLE assesses agent performance through a set of tasks spanning structure retrieval, sequence generation, and design validation. We evaluate 15 frontier models and find that seven refuse all tasks, while the remaining models exhibit substantial performance differences. Claude Sonnet 4 and Gemini 3 Pro achieve the highest scores across information retrieval, tool selection, and tool use. We further compare model performance on a subset of tasks against an expert human baseline. Our results suggest that current LLMs can substantially lower barriers to protein design, but remain inconsistent in planning, strategy generation, and integrating biological knowledge with tool use.

0.57

BioXArena-Pro: a research-grade benchmark for autonomous biomedical machine learning agents

cs.LG ·2026-11-10 ·Loka Li, Duzhen Zhang, Xingbo Du, Leonard Song, Kun Zhang +1 more
benchmarkcode/data similarity 0.72
Abstract · 51 pages (22 main text, 29 supplementary information), 5 figures, 7 supplementary tables. Code: https://github.com/mbzuai-ai4bio/BioXArena-P…

Coding agents are increasingly proposed as autonomous builders of biomedical models, but existing benchmarks are small, near saturation or open to leaked information. We present BioXArena-Pro, 64 research-level modelling tasks from eight biomedical domains, each rebuilt from a published study; most hold out whole biological units such as species or cohorts. Across 22 agent configurations, the best scores 55.1 of 100, and the scaffold matters almost as much as the model. We re-ran a published method for every task: where the published recipe applies unchanged, the best agent and the methods tie; on rebuilt tasks the methods trail by 8.2 points, suggesting that agents gain by adapting to new data. Pretrained models (including biological foundation models) matter where the strongest agent uses them: forbidding them decreases its score on those tasks by 9 points. Every task was audited in several AI-assisted rounds and a final human review.

0.34

GenomeHarness: Harnessing Al Agents for Reliable Adaptation of Genome Language Models

cs.CE ·2026-08-22 ·Weicai Long, Yusen Hou, Houcheng Su, Junning Feng, Yanlin Zhang
benchmark similarity 0.71
Abstract · 10 pages, 4 figures

Pretrained genome language models provide reusable representations for DNA sequence analysis, but turning them into reliable downstream predictors remains non-trivial. Their practical performance depends strongly on fine-tuning recipes, and default recipes reported in prior studies may be suboptimal for new tasks or model backbones, making weak downstream results difficult to interpret. These requirements place a substantial operational burden on many intended users, whose expertise is often centered on biological questions and interpretation rather than machine-learning engineering. Reliable use of genome language models therefore requires more than conventional AutoML-style tuning: it requires a systematic, budget-aware, and auditable procedure that lowers the barrier to downstream adaptation. We present GenomeHarness, an agentic harness for adapting genome language models through controlled search over fine-tuning recipes. GenomeHarness combines an AI agent for proposing and repairing recipe edits, a harness for protocol-constrained execution, resource management, and test isolation, and a Monte Carlo tree search controller for allocating search effort across recipe lineages. We evaluate GenomeHarness on DNABERT2 and NTv2-100M-Multi across the NT Benchmark and Genomic Benchmarks. Final evaluation is performed using three random seeds after recipe freezing. Across 52 model-task settings, GenomeHarness improves mean test MCC in 47 settings, including 24 of 26 DNABERT2 settings and 23 of 26 NTv2-100M-Multi settings. The gains are especially pronounced on Genomic Benchmarks and on tasks where the root recipe is unstable or poorly matched, such as human ocr ensembl task. Search traces further show that GenomeHarness progressively identifies stronger recipes, turning downstream adaptation into a controlled and auditable workflow rather than a manual tuning process.

0.22

NIBench: benchmarking autonomous AI agents for execution, skill evolution and scientific judgment in neuroimaging

cs.AI ·2026-11-11 ·Lujia Zhong, Yihao Xia, Jianwei Zhang, Shuo Huang, Xinyu Nie +6 more
benchmark similarity 0.71
Abstract

Autonomous AI agents are increasingly used to automate biomedical research, creating a growing need to benchmark their capabilities on real scientific data and workflows. Their reliability in neuroimaging remains insufficiently characterized, where plausible analytical outputs can conceal errors that affect scientific conclusions. Existing studies have advanced scientific question answering and tool-based automation, but provide limited evidence on workflow reconstruction, acquisition of procedural expertise and evidence-based scientific judgment. Here we present NIBench, a neuroimaging benchmark comprising three complementary evaluations of autonomous agents. First, we benchmark execution and workflow reconstruction using 56 tasks across seven tool ecosystems, covering structural, diffusion and functional magnetic resonance imaging, positron emission tomography and multimodal analyses. Second, we examine whether agents can evolve their procedural skills through distillation of execution trajectories, evaluating the resulting skills on previously encountered tasks, unseen tasks and other models. Third, we assess scientific judgment using 36 claims from published Alzheimer's disease studies, requiring agents to analyse raw cohort data and provide reproducible evidence. We evaluate 19 language models within a shared agent framework, with selected models undergoing skill distillation and claim evaluation. Leading agents execute supplied analysis protocols nearly perfectly, whereas withholding procedural guidance widens performance differences. Distilled skills improve performance on acquisition tasks and transfer between models, but benefits on unseen tasks are inconsistent. Agents reproduce their reported results yet sometimes reach conclusions inconsistent with expert-derived answers, and access to data does not always improve judgment.

0.11

BixBench3: Benchmarking AI agents on research-study-scale computational biology tasks

cs.AI q-bio.QM ·2026-08-26 ·Zane Koch, Asmamaw T. Wassie, Javier Valdes-Aleman, Jason Lee, Michaela M. Hinks +3 more
benchmarkhighly cited similarity 0.70
Abstract · 28 pages, 6 figures

Artificial intelligence (AI) promises to accelerate biological research by automating computational analyses. Yet the ability of AI agents to execute on computational biology at the scale of complete research studies has not been systematically evaluated. Here we introduce BixBench3, a benchmark that measures the capacity of AI agents to process raw biological data through to scientific results. We designed BixBench3 tasks to mirror the delegation of work from a scientist to an agent: the scientist chooses the research question and high-level methods, then delegates implementation of all analyses to the agent. In each task, an agent receives a research objective, methodological guidance, and raw data derived from a published scientific study, and must execute a sequence of analyses to achieve the research objective. The data artifacts resulting from these analyses, such as peak call matrices or differential expression tables, are programmatically graded against the corresponding artifacts generated and reported in the original study. Across 20 BixBench3 tasks encompassing the generation of 138 unique artifacts, we find that 13 frontier models achieve scores ranging from 0.00 for Gemini 3.1 Flash Lite to 0.48 for GPT 5.6 Sol. Agents perform worse on tasks with larger raw datasets (0.36 on tasks with <100 GB versus 0.10 on tasks with >100 GB) and on analyses requiring more sequential steps (0.36 at 1-2 steps vs 0.24 at 3+). On average, agents use 6.8 hours, 102 million tokens, and \$43 to complete each task, with the longest attempts consuming 24 hours, 1.07 billion tokens, and \$525. Notably, the highest-scoring agents used fewer tokens and were cheaper than less performant options. These results reveal that LLMs vary substantially in their ability to (1) execute multiple sequential analysis steps coherently, (2) manage large quantities of raw data, and (3) work across scientific domains.

0.43

DrugCoding: A Scientific Programming Agent for Drug Discovery

cs.AI cs.MA ·2026-11-10 ·Junwei Hu, Zhuohao Lin, Kun Li, Hengnan Zhang
benchmark similarity 0.70
Abstract

Drug discovery involves multiple interconnected research stages, including molecular design, property prediction, and virtual screening. These processes are characterized by complex workflows, interdependent computational tasks, and diverse specialized tools, placing substantial demands on the coordination of scientific models and computational resources. However, existing large language model (LLM)-based scientific agents still face challenges in autonomous planning of complex tasks, adaptive selection of specialized models, and reliable execution of multi-stage scientific computations, limiting their effectiveness in automating complex drug discovery workflows. To address these challenges, we propose DrugCoding, a scientific programming agent system that integrates scientific task planning, adaptive model routing, multi-agent collaboration, and programmatic tool execution. DrugCoding enables autonomous task planning and dynamic model adaptation for complex research objectives. It can flexibly invoke specialized scientific models, autonomously generate and execute code according to task requirements, and leverage multi-agent collaboration to support efficient execution and reliable validation of complex scientific tasks. To evaluate DrugCoding's performance in scientific tool invocation and multi-stage task execution, we conduct multi-turn tool-calling experiments across diverse language models and scientific tool interfaces. Experimental results demonstrate that DrugCoding achieves an average session-level Pass@1 of 97.35% on the full benchmark, outperforming the strongest baseline, Codex, by 9.24%. On the challenging subset, DrugCoding achieves 97.92%, exceeding the strongest baseline.

0.17